Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jopabinia
    Junior Member
    • Jul 2015
    • 1

    #1

    RNASeq study design with different species and tissues

    I am in the process of sequencing transcriptomes for RNASeq/differential expression from 8 nonmodel invertebrate species, for 3 tissues * 3 biological replicates each. 4 of these species have a phenotype of interest and 4 do not. We know the phylogeny, and each of the 4 species with the phenotype evolved it independently (the other 4 species are for sister group comparison).

    I want to investigate differential expression across these 8 species AND 3 tissues AND convergent evolution.

    The research questions:
    1) Is variation in expression more strongly attributed to species or tissue? For this, I think PCA in DESeq or MDS in edgeR will answer it?

    2) Are patterns of expression more similar because of phylogeny (i.e. sister species have similar expression) or because those species have the same phenotype?

    3) Is there statistically an interaction between these 2 questions, and how to account for it?

    Thanks, I am a noob at RNASeq!

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...